2026-10-12T15:25:40Z https://api.figshare.com/v2/oai

oai:figshare.com:article/34040777 2026-10-01T07:20:48Z category_37339 category_37363 category_37366 portal_1012 item_type_6 month_year_10_2026

Supplementary Table S2 from Phase I Trial of GPC3-Targeted TCR Fusion Construct, CT0180, in Patients with Advanced Hepatocellular Carcinoma Xuqi Sun (25154117) Wanwan Gao (25154120) Chunhui Shou (25154123) Junyi Yan (25154126) Qihan Fu (25154129) Yi Zheng (25154132) Lulu Liu (25154135) You Zhai (25154138) Zhou Tong (25154141) Hangyu Zhang (25154144) Bin Li (15131169) Meihua Lin (25154147) Xudong Zhu (25154150) Yumeng Wang (25154153) Daijing Yuan (25154156) Xuanwen Bao (15131124) Xiaomeng Dai (15131139) Yi Luo (25154159) Hua Jiang (25154162) Huamao Wang (25154165) Peng Zhao (15131199) Qingwei Zhao (25154168) Weijia Fang (15131190) Zonghai Li (25154171) Tingbo Liang (25154174) Cancer Immuno-oncology Clinical Research and Trials Clinical-stage Research Gastrointestinal Cancers Liver cancer Immunotherapy Engineered/CAR T cells <p>Patient-level CT0180 treatment exposure</p> 2026-10-01T00:00:00Z Text Journal contribution 10.1158/1078-0432.34040777 https://figshare.com/articles/journal_contribution/Supplementary_Table_S2_from_Phase_I_Trial_of_GPC3-Targeted_TCR_Fusion_Construct_CT0180_in_Patients_with_Advanced_Hepatocellular_Carcinoma/34040777 CC BY